Gene · 6282
Papers1,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive analysis of single-cell and bulk transcriptome unravels immune landscape of atherosclerosis and develops a S100 family based-diagnostic model. | Comput Biol Chem | 2025 | 40163962 | PubTator, text mining | PubMed |
| New insights into tumor microenvironment and HPV integrations in cervical cancer pathogenesis revealed by single-cell transcriptome data. | Hum Mol Genet | 2025 | 40151001 | PubTator, text mining | PubMed |
| Clinical Response Characteristics of Salivary Proteins in the Management Strategy of Diabetes-Associated Periodontitis. | J Proteome Res | 2025 | 40008981 | PubTator, text mining | PubMed |
| An anoikis-related signature predicts prognosis and immunotherapy response in gastrointestinal cancers. | Front Immunol | 2025 | 39981252 | PubTator, text mining | PubMed |
| Annexin A1 in neurological disorders: Neuroprotection and glial modulation. | Pharmacol Ther | 2025 | 39900227 | PubTator, text mining | PubMed |
| Hsa_circ_0000105 promotes nasopharyngeal carcinoma malignancy by miR-541-3p/S100A11 axis. | Clinics (Sao Paulo) | 2025 | 39879906 | PubTator, text mining | PubMed |
| Comprehensive analysis reveals cholesterol metabolism-related signature for predicting prognosis and guiding individualized treatment of glioma. | Heliyon | 2025 | 39866460 | PubTator, text mining | PubMed |
| Preliminary screening of new biomarkers for sepsis using bioinformatics and experimental validation. | PLoS One | 2025 | 39854580 | PubTator, text mining | PubMed |
| Deciphering Immunometabolic Landscape in Rheumatoid Arthritis: Integrative Multiomics, Explainable Machine Learning and Experimental Validation. | J Inflamm Res | 2025 | 39835297 | PubTator, text mining | PubMed |
| Narciclasine attenuates sepsis-associated acute kidney injury through the ESR1/S100A11 axis. | Funct Integr Genomics | 2025 | 39808340 | PubTator, text mining | PubMed |
| Identification of Biomarkers Related to Liquid-Liquid Phase Separation for Ulcerative Colitis Based on Single-Cell and Bulk RNA Transcriptome Sequencing Data. | Endocr Metab Immune Disord Drug Targets | 2025 | 39791167 | PubTator, text mining | PubMed |
| Apoptotic breast cancer cells after chemotherapy induce pro-tumour extracellular vesicles via LAP-competent macrophages. | Redox Biol | 2025 | 39756316 | PubTator, text mining | PubMed |
| S100A proteins show a spatial distribution of inflammation associated with the glioblastoma microenvironment architecture. | Theranostics | 2025 | 39744679 | PubTator, text mining | PubMed |
| S100A11 promotes lipid metabolism and activates the apoptosis in polycystic ovary syndrome. | Reproduction | 2025 | 39679898 | PubTator, text mining | PubMed |
| Microbiota-induced S100A11-RAGE axis underlies immune evasion in right-sided colon adenomas and is a therapeutic target to boost anti-PD1 efficacy. | Gut | 2025 | 39251326 | PubTator, text mining | PubMed |
| Integrating single-cell RNA-Seq and machine learning to dissect tryptophan metabolism in ulcerative colitis. | J Transl Med | 2024 | 39707393 | PubTator, text mining | PubMed |
| S100A11 is a potential prognostic biomarker and correlated with tumor immunosuppressive microenvironment in glioma. | Medicine (Baltimore) | 2024 | 39705426 | PubTator, text mining | PubMed |
| Proteomic Profiling of Pre- and Post-Surgery Saliva of Glioblastoma Patients: A Pilot Investigation. | Int J Mol Sci | 2024 | 39684695 | PubTator, text mining | PubMed |
| Hierarchical marker genes selection in scRNA-seq analysis. | PLoS Comput Biol | 2024 | 39666603 | PubTator, text mining | PubMed |
| Endogenous antigens shape the transcriptome and TCR repertoire in an autoimmune arthritis model. | J Clin Invest | 2024 | 39589811 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6282/papers?page=5